Clindamycin bpo

Clindamycin-BPO 2.5% gel was compared with the individual active ingredients (clindamycin phosphate 1.2% and BPO 2.5%) and vehicle over 12 weeks. Clindamycin-

clindamycin (acne of any severity), BPO or BPO/clindamycin (mild generic questionnaires. Br J Dermatol. 2024;12–6

Clindamycin-BPO 2.5% gel was compared with the individual active ingredients (clindamycin phosphate 1.2% and BPO 2.5%) and vehicle over 12 weeks. Clindamycin-

tretinoin/clindamycin (acne of any severity), BPO or BPO/clindamycin Combined Acne Severity Classification with a lesion count ≥ 10 [1].

In the IDP-126 phase 2 study, the combination of clindamycin, BPO, and adapalene (IDP-126) appeared to have had a slightly better safety and tolerability profile compared with the adapalene/BPO dyad. 15 Several split-face studies comparing topical dyads that contained clindamycin phosphate/BPO or adapalene/BPO demonstrated that clindamycin/BPO

Clindamycin-BPO 2.5% gel was compared with the individual active ingredients (clindamycin phosphate 1.2% and BPO 2.5%) and vehicle over 12 weeks. Clindamycin

clindamycin (acne of any severity), BPO or BPO/clindamycin (mild-moderate acne), and addition of an oral antibiotic to topical therapy

by TN Canavan 2024 Cited by 66retinoids, benzoyl peroxide (BPO), clindamycin, clindamycin combined with BPO and adapalene combined with BPO (Table 1). Because clindamycin

Clindamycin-BPO 2.5% gel was compared with the individual active ingredients (clindamycin phosphate 1.2% and BPO 2.5%) and vehicle over 12 weeks. Clindamycin-